Yoshiro Tomono

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4′-hydroxylation status

Sanae Yasuda, Yukio Horai, Yoshiro Tomono et al. · Clinical Pharmacology & Therapeutics · 1995 · 138 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly Subjects

Akihiro Ohnishi, M Mihara, Hirotoshi Kamakura et al. · The Journal of Clinical Pharmacology · 1993 · 87 citations

Medicine, Pharmacokinetics, Pharmacology +17

Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation*

Takashi Ishizaki, Kan Chiba, Kyoko Manabe et al. · Clinical Pharmacology & Therapeutics · 1995 · 79 citations

Medicine, Pharmacology, Pharmacotherapy +16

Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment

Elena Soto, Satoshi Shoji, Chieko Muto et al. · British Journal of Clinical Pharmacology · 2013 · 43 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Effect of Dietary Fat Content on Oral Bioavailability of Menatetrenone in Humans

Toshihiko Uematsu, Satoru Nagashima, Masayuki Niwa et al. · Journal of Pharmaceutical Sciences · 1996 · 39 citations

Pharmacy, Nutritional Sciences, Pharmacokinetics +14